Jefferies Maintains Buy on Insulet, Raises Price Target to $260
Portfolio Pulse from Benzinga Newsdesk
Jefferies analyst Matthew Taylor maintains a Buy rating on Insulet (NASDAQ:PODD) and raises the price target from $255 to $260.
May 10, 2024 | 1:18 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Jefferies analyst Matthew Taylor reaffirmed a Buy rating on Insulet and increased the price target to $260, indicating a positive outlook on the company's stock.
The increase in price target by a reputable analyst like Matthew Taylor from Jefferies suggests a strong bullish sentiment towards Insulet's stock. Such endorsements often lead to short-term positive movements in the stock price as they reflect confidence in the company's future growth and performance.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100